Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational - Prognostic Value of p53 and/or p16 Alterations in Ewing Sarcoma

NCT00898053 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00898053
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00898053 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational - Prognostic Value of p53 and/or p16 Alterations in Ewing Sarcoma
Lead sponsor
Children's Oncology Group
Phase
Observational
Overall status
Completed
Start date
September 30, 2008
Completion date
May 31, 2016
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

localized ewing sarcoma/peripheral primitive neuroectodermal tumor